SurvivorNet on MSN12mon
New Drug for Myelodysplastic Syndrome Advances Towards FDA Approval — What is it, Who Can benefit & What You Need to KnowThere’s some promising news for people living with myelodysplastic syndrome (MDS) as a new treatment option may reduce the ...
Myelodysplastic syndrome (MDS) can be difficult to diagnose. Many people who are diagnosed with MDS go to their doctor with some or all of the symptoms typical of MDS. Other people are diagnosed with ...
It has the potential to cure MDS. Learn more about our stem cell transplantation program. Stem cell transplants may be considered as a treatment option if you are below the age of 75 and are otherwise ...
Myelodysplastic syndromes (MDS) are clonal disorders of the hematopoietic stem cell characterized by ineffective hematopoiesis leading to peripheral cytopenias. Different processes are involved in ...
Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...
In support of a central role for NKT cells, a pilot clinical study reported that lenalidomide (an approved treatment for MDS) increased NKT cell numbers in patients with MDS, and several in vitro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback